The China Anti-Acne Drug market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.
China is expected to be a booming market for acne over the forecasted period Chinese consumers are willing to pay for branded or premium products and are less price sensitive. The prevalence of acne is more in primary and secondary students than the undergraduates. Also, chinese male face more acne related problem and this disease has a greater prevalence in southern china as compared to its Northern counterpart.
Increase in prevalence of acne diseases is the major factor that contributes toward growth of the acne medication market. Moreover, other factors that fuel the market include unhealthy urban lifestyle and presence of robust acne medications in pipeline. However, side-effects associated with the use of acne medications and presence of alternative treatment impede the market growth. Conversely, development of effective medications with lesser side effects and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.